<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000508667"><TermName>Dacogen</TermName><TermPronunciation>(DA-koh-jen)</TermPronunciation><TermDefinition><DefinitionText>A drug that is used to treat myelodysplastic syndromes and is being studied in the treatment of other types of cancer. It is a type of antimetabolite. Also called decitabine.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000718272" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Dacogen&quot;" language="en" id="_3"/><MediaLink ref="CDR0000718271" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Dacogen&quot;" language="es" id="_4"/><SpanishTermName>Dacogen</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar los síndromes mielodisplásicos y que se estudia para tratar otros tipos de cáncer. Es un tipo de antimetabolito. También se llama decitabina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2006-09-15</DateFirstPublished><DateLastModified>2007-07-06</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000495366">Decitabine</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
